To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06518564
Title Avelumab and M1774 in ARID1A-mutated Endometrial Cancer (Prior IO)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Panagiotis Konstantinopoulos, MD, PhD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA